GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Total Operating Expense

Eris Lifesciences (BOM:540596) Total Operating Expense : ₹14,635 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Total Operating Expense?

Eris Lifesciences's Total Operating Expense for the three months ended in Mar. 2025 was ₹3,578 Mil. Eris Lifesciences's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹14,635 Mil.

Eris Lifesciences Total Operating Expense Historical Data

The historical data trend for Eris Lifesciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Total Operating Expense Chart

Eris Lifesciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,620.02 6,403.00 8,825.47 11,189.30 14,635.30

Eris Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,344.60 3,609.50 3,686.50 3,761.30 3,578.00

Eris Lifesciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹14,635 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eris Lifesciences Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Total Operating Expense
Comparable Companies
BOM:506820 BOM:532300 BOM:533573 BOM:530019 BOM:524742 BOM:544210 NSE:GLAND BOM:524816 BOM:506943 BOM:524558 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
ERIS:India
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Website
https://www.eris.co.in
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences Headlines

No Headlines